Our Research

With suicide as the 2nd leading cause of death in the United States among individuals aged 10 – 34, and 1 in 5 adults battling a mental illness, the need for quality behavioral health care and innovative scientific advancements has never been more prevalent. Yet without addressing the core psychological distress behind an individual’s mental health or substance abuse disorder, many will continue to live lives dominated by these difficult but ever-present behavioral health concerns.

Since our inception, we at Retreat have remained dedicated to addressing the heart of these issues, eradicating the stigmas that surround them, and embracing the innovative thinking that can lead to tangible treatment options.

Dr. Brian Berman, PSYD

The Choice-Point Model

In the realm of scientific inquiry, research is constantly evolving. Yet, there exists very little in-depth research when it comes to substance abuse, most especially in inpatient settings.

– Dr. Berman

As a full-time clinical psychologist with Retreat Behavioral Health, Dr. Brian Berman’s [PSYD] main priority is patient care. Utilizing treatments such as acceptance and commitment therapy (ACT), he incorporated an evidence-based practice proficient at treating mental health and substance use disorders. Dr. Berman continues to innovate through his research with the “choice point model” of ACT (CPM-ACT), one of the most cutting-edge approaches.

Because Dr. Berman and his outstanding team dedicated the past 4 years to pioneering research, patient care has profited. Dr. Berman’s study showed that those who attended Retreat’s ACT program became more accepting of their emotions, made healthier life decisions and exhibited increased self-compassionate. This is significant and suggests that Retreat residents learn the mental health and recovery skills necessary for success. Additionally, because therapeutic benefits were witnessed after only two weeks, Retreat residents should expect improvements regardless of length of stay.

Publications

Research

Berman, B. M., Kurlancheek, K., Hartranft, B., & Longenecker, T. (2020). Treatment Maintenance and Beyond with Substance Use Disorders: A Sleeper Effect. Poster presented at the Association for Contextual Behavioral Science (ACBS) World Conference. Virtual.

Berman, B. M., Kurlancheek, K., Hartranft, B., & Longenecker, T. (2020). Treatment Adherence with Substance Use Disorders: A Transdiagnostic Approach. Poster presented at the American Psychological Association (APA) Convention.Virtual.

Berman, B. M., Kurlancheek, K., & Hartranft, B. (2020). Transdiagnostic and Compassionate Innovations in Relapse Prevention. Poster presented at the American Society of Addiction Medicine (ASAM) Conference. Virtual. Link to Abstract

Berman, B. M., Troncale, J., Kurlancheek, K., Hartranft, B. & Ramsey, K. (2019). The Choice Point Model of Acceptance and Commitment Therapy in an Inpatient Substance Use Disorder Setting: A Pilot Study. Substance Abuse. 40(4), 389-391. Link to Abstract

Articles

Berman, B. M. (2017, April). Supercharging Recovery With Exposure Therapy. Sober World, 6 (4), 16.
Berman, B. M. (2016, March). Self-Compassion: A Bridge to Recovery.  The 12 Step Gazette, (58), 34.
Berman, B. M. (2016, February). Values Illness. Sober World, 5 (2), 10.